PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could let kids with peanut allergies eat nuts safely
Disease control OngoingThis study tests a new treatment called PVX108 for children and teens with peanut allergies. The goal is to see if it is safe and helps them tolerate more peanut protein without a reaction. About 90 participants will receive either the treatment or a placebo, and their peanut tol…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: Aravax Pty Ltd • Aim: Disease control
Last updated May 26, 2026 09:38 UTC
-
Peanut allergy treatment study tracks real-world success in 500 patients
Disease control OngoingThis study follows 500 people aged 6 months to 65 years with peanut allergy who are undergoing oral immunotherapy (eating small, increasing amounts of peanut protein). The main goal is to see how many can tolerate a daily maintenance dose of 300 mg peanut protein without symptoms…
Matched conditions: PEANUT ALLERGY
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 09:37 UTC
-
Peanut allergy vaccine shows promise in early safety trial
Disease control OngoingThis early-stage study tests a new treatment called VLP Peanut in 46 healthy adults and those with peanut allergy. The main goal is to see if it is safe and tolerable, while also looking for early signs that it might reduce allergic reactions. Participants receive the treatment a…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1 • Sponsor: Allergy Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC